Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery P Struewing

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Breast Disease|February 3, 2005
Genomic approaches to identifying breast cancer susceptibility factorsJeffery P Struewing
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genesDavid J Kaufman, Terri H Beaty, Jeffery P Struewing
Nucleic Acids Research|December 6, 2002
HapScope: a software system for automated and visual analysis of functionally annotated haplotypesJinghui Zhang, William L Rowe, Jeffery P Struewing, et al.
European Journal of Medical Genetics|December 26, 2007
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999Gabriel Chodick, Jeffery P Struewing, Elaine Ron, et al.
European Journal of Human Genetics : EJHG|April 29, 2004
BRCA1 and sex ratioJeffery P Struewing, Patricia Hartge, Sholom Wacholder, et al.
Science (New York, N.Y.)|December 29, 2004
Breast cancer risks for BRCA1/2 carriersSholom Wacholder, Jeffery P Struewing, Patricia Hartge, et al.
American Journal of Epidemiology|August 23, 2006
Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologistsParveen Bhatti, Deanna M Church, Joni L Rutter, et al.
Oncogene|July 11, 2003
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARFJoni L Rutter, Alisa M Goldstein, Michael R Dávila, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive historyPatricia Hartge, Nilanjan Chatterjee, Sholom Wacholder, et al.
Plos One|March 12, 2009
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanomaPhuong L Mai, Nilanjan Chatterjee, Patricia Hartge, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Breast Disease|February 3, 2005
Genomic approaches to identifying breast cancer susceptibility factorsJeffery P Struewing
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genesDavid J Kaufman, Terri H Beaty, Jeffery P Struewing
Nucleic Acids Research|December 6, 2002
HapScope: a software system for automated and visual analysis of functionally annotated haplotypesJinghui Zhang, William L Rowe, Jeffery P Struewing, et al.
European Journal of Medical Genetics|December 26, 2007
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999Gabriel Chodick, Jeffery P Struewing, Elaine Ron, et al.
European Journal of Human Genetics : EJHG|April 29, 2004
BRCA1 and sex ratioJeffery P Struewing, Patricia Hartge, Sholom Wacholder, et al.
Science (New York, N.Y.)|December 29, 2004
Breast cancer risks for BRCA1/2 carriersSholom Wacholder, Jeffery P Struewing, Patricia Hartge, et al.
American Journal of Epidemiology|August 23, 2006
Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologistsParveen Bhatti, Deanna M Church, Joni L Rutter, et al.
Oncogene|July 11, 2003
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARFJoni L Rutter, Alisa M Goldstein, Michael R Dávila, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive historyPatricia Hartge, Nilanjan Chatterjee, Sholom Wacholder, et al.
Plos One|March 12, 2009
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanomaPhuong L Mai, Nilanjan Chatterjee, Patricia Hartge, et al.
Pageof 5